Protocol Ledger

NCT06679855 · Phase III · RECRUITING

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

Interventional Phase III clinical trial protocol NCT06679855 sponsored by NICHD Neonatal Research Network in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-06-13 Enrollment: 316 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06679855
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)316 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06679855
Protocol FieldVerified Registry Value
NCT IdentifierNCT06679855
Consolidated Lead SponsorNICHD Neonatal Research Network
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment316 participants (ESTIMATED)
Registered Start Date2025-06-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI